YEWB Stock: Yew Bio-Pharm Group, Inc. Stock Price, Analysis & Insights

Get live YEWB stock price $0.00, comprehensive Yew Bio-Pharm Group, Inc. stock analysis, charts, news, and expert forecast. Real-time YEWB stock data and investment insights.

Quick links:Financial Metrics•Earnings•Analyst Forecasts•Financials•Technicals

0.00

80.00%Today

YEWB • Yew Bio-Pharm Group, Inc. • Other OTC • Consumer Defensive

Market Cap

11.84K

Volume

515

52W High

0.00

52W Low

0.00

Loading chart data...

Investment Score

Annual (latest period)

Unavailable

A systematic tri-factor framework that integrates valuation, business quality, and market momentum into one investment signal. This helps investors triage opportunities faster, while surfacing risk regimes that may require tighter position sizing or deeper due diligence.

Score unavailable for this asset.

View full dashboardUnlock quarterlyFaster signals · Pro+

0-39

Defensive posture

40-54

Mixed / wait for confirmation

55-69

Constructive setup

70-100

Attractive zone

Total Score

Value

Cheapness vs fundamentals and cash generation

Quality

Durability of profitability and balance sheet

Momentum

Price trend strength and persistence

Professional usage: treat the score as a ranking and risk-filtering tool, then confirm with earnings revision trend, competitive positioning, and valuation relative to peers before capital allocation.

Company Overview

Yew Bio-Pharm Group, Inc. (YEWB) operates as a cultivator and purveyor of yew trees across both the People's Republic of China and the United States, utilizing its subsidiaries. A significant portion of its operations involves supplying raw yew mater...

Contact Information

Website: https://www.yewbiopharm.com
Address: 9460 Telstar Avenue
Country: US

Investment Analysis & Business Insights

Consumer Defensive

Agricultural Farm Products

Investment Highlights

✓ Strong presence in the Consumer Defensive sector with established market position

✓ Valuation metrics suggest potential value opportunity (P/E: 0.0)

✓ Lower volatility stock (Beta: -0.68) may provide portfolio stability

Important Investment Considerations

⚠All investments carry risk, including potential loss of principal for Yew Bio-Pharm Group, Inc. shareholders
⚠Market volatility can significantly impact stock price, especially for smaller companies
⚠Sector-specific risks in Consumer Defensive may affect company performance
⚠Past performance does not guarantee future results for Yew Bio-Pharm Group, Inc.
⚠Investors should consider how Yew Bio-Pharm Group, Inc. fits within their overall portfolio allocation
⚠Valuation metrics suggest potential, but require fundamental analysis

Market Cap

11.84K

P/E Ratio (TTM)

0.02

Beta

-0.68

Data Sources & Methodology

Financial data on this page is sourced from verified SEC EDGAR filings (10-K, 10-Q, 8-K reports), real-time market data providers, and official company disclosures. All analysis is generated using AI models trained exclusively on reliable financial documents. For detailed information about our data sources and methodology, see our Methodology page.Not investment advice.